Haloprogin
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Haloprogin
|
|
| Systematic (IUPAC) name | |
| 1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C9H4Cl3IO |
| Mol. mass | 361.39 |
| Physical data | |
| Melt. point | 113.5 °C (236 °F) |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Not available in U.S. |
| Routes | Topical |
Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections. It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.
[edit] Action
Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over the counter primarily to treat tinea infcections of the skin. The mechanism of action is unknown.[1]
Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[2]
[edit] References
- ^ Haloprogin. Drugs@FDA. Food and Drug Administration. Retrieved on February 17, 2007.
- ^ Haloprogin. DrugBank. University of Alberta (Nov 06, 2006). Retrieved on February 17, 2007.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
